FDA warns of risks relating to potent synthetic nicotine found in vapes
In a rapidly evolving landscape of nicotine alternatives, the emergence of synthetic compounds like 6-methyl nicotine presents a new frontier fraught with uncertainty. The U.S. FDA and independent researchers suggest these substitutes, despite similarities to nicotine, may harbour heightened potency and addictive potential. With regulatory loopholes allowing their unfettered entry into markets, concerns mount over the unforeseen health ramifications. As the industry navigates uncharted territory, pivotal questions loom about the safety and regulation of these novel substances.
Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.
By Emma Rumney
Nicotine alternatives used in vapes being launched in the U.S. and abroad, such as 6-methyl nicotine, may be more potent and addictive than nicotine itself, though the scientific data remains incomplete, according to the U.S. Food and Drug Administration (FDA) and independent researchers.
___STEADY_PAYWALL___